Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai International Medical Center operates as a high-end general hospital integrating international medical standards and multidisciplinary care. It has participated in early-stage clinical research involving precision cell immunotherapy targeting PD‑1 for advanced cancers. The center collaborates with leading academic hospitals and offers comprehensive inpatient and outpatient services. No late-stage or commercial drug assets are reported.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai International Medical Center.